lai wen - Net Worth and Insider Trading

lai wen Net Worth

The estimated net worth of lai wen is at least $11,650 dollars as of 2024-11-07. lai wen is the Executives of Chongqing Lummy Pharmaceutical and owns about 2,500 shares of Chongqing Lummy Pharmaceutical (SZSE:300006) stock worth over $11,650. Details can be seen in lai wen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that lai wen has not made any transactions after 2024-10-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of lai wen

To

lai wen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, lai wen owns 1 companies in total, including Chongqing Lummy Pharmaceutical (SZSE:300006) .

Click here to see the complete history of lai wen’s form 4 insider trades.

Insider Ownership Summary of lai wen

Ticker Comapny Transaction Date Type of Owner
SZSE:300006 Chongqing Lummy Pharmaceutical 2024-10-23 Executives

lai wen Latest Holdings Summary

lai wen currently owns a total of 1 stock. lai wen owns 2,500 shares of Chongqing Lummy Pharmaceutical (SZSE:300006) as of October 23, 2024, with a value of $11,650.

Latest Holdings of lai wen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SZSE:300006 Chongqing Lummy Pharmaceutical 2024-10-23 2,500 4.66 11,650

Holding Weightings of lai wen


lai wen Form 4 Trading Tracker

According to the SEC Form 4 filings, lai wen has made a total of 1 transactions in Chongqing Lummy Pharmaceutical (SZSE:300006) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Chongqing Lummy Pharmaceutical is the acquisition of 2,500 shares on October 23, 2024, which cost lai wen around $9,800.

Insider Trading History of lai wen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

lai wen Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

lai wen Ownership Network

Ownership Network List of lai wen

No Data

Ownership Network Relation of lai wen

Insider Network Chart

lai wen Owned Company Details

What does Chongqing Lummy Pharmaceutical do?

Who are the key executives at Chongqing Lummy Pharmaceutical?

lai wen is the Executives of Chongqing Lummy Pharmaceutical. Other key executives at Chongqing Lummy Pharmaceutical include Supervisors Yuan Yuan , Directors & executives Qiu Yu , and Secretary & Director Leng Xue Feng .

Chongqing Lummy Pharmaceutical (SZSE:300006) Insider Trades Summary

Over the past 18 months, lai wen made 1 insider transaction in Chongqing Lummy Pharmaceutical (SZSE:300006) with a net purchase of 2,500.

In summary, during the past 3 months, insiders sold 0 shares of Chongqing Lummy Pharmaceutical (SZSE:300006) in total and bought 2,500 shares, with a net purchase of 2,500 shares. During the past 18 months, 0 shares of Chongqing Lummy Pharmaceutical (SZSE:300006) were sold and 2,500 shares were bought by its insiders, resulting in a net purchase of 2,500 shares.

Chongqing Lummy Pharmaceutical (SZSE:300006)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Chongqing Lummy Pharmaceutical Insider Transactions

No Available Data

lai wen Mailing Address

Above is the net worth, insider trading, and ownership report for lai wen. Currently GuruFocus does not have mailing address information for lai wen.